CUE Cue Biopharma
Company Analysis
Latest News
🟢 Cue Biopharma is trading 40.69% up in pre-market after CUE-221 achieved 54% complete hive resolution
Cue Biopharma is trading 40.69% up at $52.13 after positive Phase 2 results for CUE-221 in chronic spontaneous urticaria. • The highest dose produced 54%...
Cue Biopharma Hives Drug Hits Phase 2 Goals, Showing 54% Resolution
Cue Biopharma reported positive topline results from a Phase 2 trial of CUE-221 for moderate to severe chronic spontaneous urticaria (CSU). The study involved...
B. Riley Slaps an $83 Target on Cue Biopharma at $40 — Can a Single Drug Candidate Justify Doubling the Stock?
Shares of Cue Biopharma surged as much as 7.9% to $39.99 on September 19 after B. Riley Securities launched coverage with a Buy rating and an $83 price target...
🟢 Cue Biopharma is trading 7.94% up in after-hours trading after B. Riley initiated coverage with a Buy rating
Cue Biopharma is trading 7.94% up at $39.99 in after-hours trading after B. Riley initiated coverage with a Buy rating on September 18, 2026. - B. Riley set...
🟢 Cue Biopharma is trading 6.4% up today after B. Riley initiated coverage with a Buy rating
Cue Biopharma is trading 6.4% up at $40.27 after B. Riley initiated coverage on September 18, 2026, with a Buy rating and an $83.00 price target, citing...
🟢 Cue Biopharma rises 5.4% — Biotech Sector Rallies on Strong Industry Outlook and M&A Optimism
With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as measured by the XBI ETF,...
🟢 Cue Biopharma is trading 12% up today — no confirmed catalyst identified
Cue Biopharma is trading at $35.47 (+12.10%), with no new company-specific announcement or confirmed catalyst identified for September 16, 2026. - Recent...
🟢 Cue Biopharma is trading 5.9% up today as catalyst remains unclear
Cue Biopharma is trading 5.9% up at $33.49, with no new company-specific announcement identified for September 16, 2026 and the catalyst unclear. - Latest...
🟢 Cue Biopharma is trading 6.9% up with no clear catalyst identified
Cue Biopharma is trading 6.9% up now at $30.71, with no clear catalyst identified. - No company-specific announcement or analyst action dated September 14,...
🔴 Cue Biopharma is trading 6.33% down today as hotter-than-expected August PPI lifted Treasury yields
Cue Biopharma is trading at $28.57, down -6.33%, amid broader risk-off sentiment after hotter-than-expected August PPI lifted Treasury yields and pressured...
🟢 Cue Biopharma is trading 5.93% up today — no clear catalyst identified
Cue Biopharma is trading 5.93% up now at $31.78, with no clear catalyst identified. - The stock rose from the September 8 close of $30.00. - No...
🔴 Cue Biopharma is trading 5.8% down in after-hours trading with no clear company-specific catalyst identified
Cue Biopharma is trading 5.81% down at $28.26 after no clear company-specific catalyst emerged in available September 8, 2026 coverage. - Latest identified...
🟢 Cue Biopharma is trading 5.45% up today — no clear catalyst identified
Cue Biopharma is trading 5.45% higher at $28.93, with no clearly reported company-specific catalyst identified for September 8, 2026. - Broader markets are...
🔴 Cue Biopharma is trading 12% down today despite biotechnology strength
Cue Biopharma is trading 11.95% down at $25.04, with no clear company-specific catalyst identified for September 2, 2026. - Investor relations’ latest listed...
🔴 Cue Biopharma is trading 7% down today with no clear company-specific catalyst
Cue Biopharma is trading 7.24% down now at $26.38 after no clear company-specific catalyst was identified for September 2, 2026. - The latest company release,...
🟢 Cue Biopharma is trading 11.4% up today with no clear catalyst identified
Cue Biopharma is trading 11.4% up at $28.43, with no clear company-specific catalyst identified for September 1, 2026. - The move follows an 8.46% decline on...
🟢 Cue Biopharma is trading 5.31% up today with no clear catalyst identified
Cue Biopharma is trading 5.31% up at $26.88, rebounding after its 8.46% decline on August 31, 2026, with no new company-specific announcement or clearly...
🔴 Cue Biopharma is trading 6.35% down today with no new company-specific catalyst identified
Cue Biopharma is trading 6.35% down at $26.11, with no new company-specific catalyst identified for August 31, 2026. - The decline follows a sharp late-August...
🟢 Cue Biopharma is trading 5.65% up today — no clear catalyst identified
Cue Biopharma is trading 5.65% up now at $29.75 after a sharp multi-session advance, with no clear catalyst identified. - Shares gained 15.44% on August 25...
🔴 Cue Biopharma is trading 7.04% down today after reversing sharply from recent gains
Cue Biopharma is trading 7.04% down at $26.82 after reversing sharply from recent gains. - The stock rose 15.44% on August 25 and 7.81% on August 26 before...